Volume 30, Number 12—December 2024
Dispatch
Influenza A Virus Antibodies in Ducks and Introduction of Highly Pathogenic Influenza A(H5N1) Virus, Tennessee, USA
Table 2
Time sampled | Hemagglutination inhibition H5† |
Virus neutralization H5† |
|||
---|---|---|---|---|---|
rg BWT | rg AST | rg BWT | rg AST | ||
Pre–H5N1 detection, Nov 7, 2021–Jan 5, 2022 | 6/63 (10) | 1/63 (2) | 21/65 (32) | 2/65 (3) | |
H5N1 detection, Jan 24–25, 2022 | 1/26 (4) | 0/26 (0) | 3/24 (13) | 1/26 (4) | |
Post–H5N1 detection, Jan 30–31, 2022 | 4/15 (27) | 3/15 (20) | 7/12 (58) | 3/12 (25) |
*Values are no. positive/no. tested (%). As determined by hemagglutination inhibition and virus neutralization using 2 H5 antigens of North American low pathogenicity IAV (reverse genetics BWT) and goose/Guangdong clade 2.3.4.4b H5 lineage of highly pathogenic IAV (reverse genetics AST). AST, IDCDC-RG71A (H5N8) with modified HA and NA from A/Astrakhan/3212/2020 (H5N8) on PR8 backbone; BWT, HA and NA from A/Blue-winged teal/AI12–4150/Texas/2012 (H5N2) on PR8 backbone; HA, hemagglutinin; HI, hemagglutination inhibition; IAV, influenza A virus; NA, neuraminidase; rg, reverse genetics; VN, virus neutralization. †Both tests completed with 2 antigens. Reverse genetics BWT antigen: HA and NA from A/Blue-winged teal/AI12–4150/Texas/2012 (H5N2) on PR8 backbone; and reverse genetics AST antigen: IDCDC-RG71A (H5N8). Modified HA and NA from A/Astrakhan/3212/2020 (H5N8) on PR8 backbone.